Detailed information for compound 588370

Basic information

Technical information
  • TDR Targets ID: 588370
  • Name: oxantrazole
  • MW: 411.454 | Formula: C21H25N5O4
  • H donors: 6 H acceptors: 4 LogP: 1.81 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 2
  • SMILES: NCCCNc1ccc2c3c1c(O)c1C(=O)C=CC(=O)c1c3[nH]n2CCNCCO
  • InChi: 1S/C21H25N5O4/c22-6-1-7-24-12-2-3-13-17-16(12)21(30)19-15(29)5-4-14(28)18(19)20(17)25-26(13)10-8-23-9-11-27/h2-5,23-25,27,30H,1,6-11,22H2
  • InChiKey: KDRKQBMPDQDAJW-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • anthrapyrazole
  • 91441-23-5
  • Piroxantrone
  • Piroxantrona [INN-Spanish]
  • Piroxantronum [INN-Latin]
  • PD-111815
  • NCI60_003106
  • Anthra(1,9-cd)pyrazol-6(2H)-one, 5-((3-aminopropyl)amino)-7,10-dihydroxy-2-(2-((2-hydroxyethyl)amino)ethyl)-
  • DuP-942
  • BRN 4725135
  • Piroxantrone hydrochloride [USAN]
  • Neuro_000181
  • CI-942
  • 5-[(3-Aminopropyl)amino]-7,10-dihydroxy-2-{2-[(2-hydroxyethyl)amino]ethyl}dibenzo[cd,g]indazol-6(2H)-one
  • AIDS-015837
  • AIDS015837
  • NSC349174(HYDROCHLORIDE)

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trichomonas vaginalis chromosome transmission fidelity factor, putative 0.001 0 0.5
Echinococcus multilocularis musashi 0.0028 0.6552 0.6552
Leishmania major 4-coumarate:coa ligase-like protein 0.0025 0.5305 0.5
Echinococcus granulosus lamin 0.0028 0.6552 0.6552
Echinococcus multilocularis lamin 0.0028 0.6552 0.6552
Plasmodium falciparum acyl-CoA synthetase 0.0018 0.3012 1
Onchocerca volvulus 0.0025 0.5305 0.8097
Loa Loa (eye worm) hypothetical protein 0.0018 0.3012 0.4596
Wolbachia endosymbiont of Brugia malayi NAD-dependent DNA ligase, Lig 0.001 0 0.5
Toxoplasma gondii ATPase, AAA family protein 0.001 0 0.5
Schistosoma mansoni transcription factor LCR-F1 0.0037 1 1
Brugia malayi Intermediate filament tail domain containing protein 0.0028 0.6552 0.6552
Trypanosoma cruzi BRCA1 C Terminus (BRCT) domain containing protein, putative 0.001 0 0.5
Trypanosoma brucei BRCA1 C Terminus (BRCT) domain containing protein, putative 0.001 0 0.5
Mycobacterium ulcerans long-chain fatty-acid CoA ligase 0.0025 0.5305 1
Schistosoma mansoni lamin 0.0028 0.6552 0.6552
Mycobacterium ulcerans hypothetical protein 0.0025 0.5305 1
Schistosoma mansoni hypothetical protein 0.0037 1 1
Echinococcus multilocularis lamin dm0 0.0028 0.6552 0.6552
Mycobacterium tuberculosis Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) 0.0025 0.5305 1
Trichomonas vaginalis replication factor C large subunit, putative 0.001 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0025 0.5305 0.8097
Onchocerca volvulus 0.0028 0.6552 1
Mycobacterium tuberculosis Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) 0.0018 0.3012 0.139
Loa Loa (eye worm) hypothetical protein 0.0018 0.3012 0.4596
Trichomonas vaginalis RNA polymerase II ctd phosphatase, putative 0.001 0 0.5
Brugia malayi cytoplasmic intermediate filament protein 0.0015 0.1761 0.1761
Trichomonas vaginalis conserved hypothetical protein 0.001 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0025 0.5305 0.8097
Mycobacterium ulcerans acyl-CoA synthetase 0.0025 0.5305 1
Echinococcus multilocularis cytoplasmic intermediate filament protein 0.0013 0.1213 0.1213
Mycobacterium ulcerans long-chain-fatty-acid-CoA ligase 0.0025 0.5305 1
Echinococcus granulosus intermediate filament protein 0.0028 0.6552 0.6552
Loa Loa (eye worm) intermediate filament protein 0.0028 0.6552 1
Trichomonas vaginalis RNA polymerase II ctd phosphatase, putative 0.001 0 0.5
Entamoeba histolytica acyl-CoA synthetase, putative 0.0025 0.5305 0.5305
Loa Loa (eye worm) hypothetical protein 0.0028 0.6552 1
Loa Loa (eye worm) hypothetical protein 0.0018 0.3012 0.4596
Loa Loa (eye worm) hypothetical protein 0.0027 0.6363 0.9712
Entamoeba histolytica hypothetical protein 0.0037 1 1
Trichomonas vaginalis conserved hypothetical protein 0.001 0 0.5
Onchocerca volvulus 0.0028 0.6552 1
Schistosoma mansoni lamin 0.0028 0.6552 0.6552
Entamoeba histolytica acyl-CoA synthetase, putative 0.0025 0.5305 0.5305
Chlamydia trachomatis acylglycerophosphoethanolamine acyltransferase 0.0018 0.3012 1
Entamoeba histolytica hypothetical protein 0.0037 1 1
Echinococcus granulosus lamin dm0 0.0028 0.6552 0.6552
Treponema pallidum DNA ligase (lig) 0.001 0 0.5
Entamoeba histolytica hypothetical protein 0.0037 1 1
Trypanosoma cruzi FHA domain containing protein, putative 0.001 0 0.5
Brugia malayi AMP-binding enzyme family protein 0.0025 0.5305 0.5305
Loa Loa (eye worm) hypothetical protein 0.0018 0.3012 0.4596
Loa Loa (eye worm) hypothetical protein 0.0018 0.3012 0.4596
Mycobacterium leprae PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) 0.0025 0.5305 1
Leishmania major 4-coumarate:coa ligase-like protein 0.0025 0.5305 0.5
Trichomonas vaginalis chromosome transmission fidelity factor, putative 0.001 0 0.5
Mycobacterium ulcerans fatty-acid-CoA ligase 0.0025 0.5305 1
Entamoeba histolytica hypothetical protein 0.0037 1 1
Trichomonas vaginalis conserved hypothetical protein 0.001 0 0.5
Mycobacterium ulcerans fatty-acid-CoA ligase 0.0018 0.3012 0.5677
Brugia malayi intermediate filament protein 0.0028 0.6552 0.6552
Mycobacterium tuberculosis Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) 0.0025 0.5305 1
Plasmodium vivax acyl-CoA synthetase, putative 0.0018 0.3012 1
Leishmania major 4-coumarate:coa ligase-like protein 0.0025 0.5305 0.5
Mycobacterium ulcerans long-chain-fatty-acid--CoA ligase 0.0025 0.5305 1
Loa Loa (eye worm) intermediate filament tail domain-containing protein 0.0028 0.6552 1
Trichomonas vaginalis conserved hypothetical protein 0.001 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0013 0.1213 0.1851
Giardia lamblia Replication factor C, subunit 1 0.001 0 0.5
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0037 1 1
Entamoeba histolytica acyl-coA synthetase, putative 0.0025 0.5305 0.5305
Brugia malayi AMP-binding enzyme family protein 0.0025 0.5305 0.5305
Echinococcus granulosus cytoplasmic intermediate filament protein 0.0013 0.1213 0.1213
Trypanosoma cruzi hypothetical protein, conserved 0.001 0 0.5
Loa Loa (eye worm) cytoplasmic intermediate filament protein 0.0015 0.1761 0.2687
Trichomonas vaginalis conserved hypothetical protein 0.001 0 0.5
Toxoplasma gondii poly(ADP-ribose) polymerase catalytic domain-containing protein 0.001 0 0.5
Brugia malayi AMP-binding enzyme family protein 0.0025 0.5305 0.5305
Loa Loa (eye worm) hypothetical protein 0.0013 0.1024 0.1563
Trypanosoma cruzi hypothetical protein, conserved 0.001 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0025 0.5305 0.8097
Loa Loa (eye worm) hypothetical protein 0.0013 0.1024 0.1563
Mycobacterium leprae PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) 0.0025 0.5305 1
Mycobacterium ulcerans acyl-CoA synthetase 0.0025 0.5305 1
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0037 1 1
Schistosoma mansoni intermediate filament proteins 0.0028 0.6552 0.6552
Mycobacterium ulcerans acyl-CoA synthetase 0.0025 0.5305 1

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.